Late Phase Solutions Europe attends RARE 2011
October 17, 2011
November 4 2011, Montpellier France
Late Phase Solutions Europe AB attends Rare 2011. If you would like to arrange a personal meeting with us during the event, please contact us at info@latephasesolutions.com
or phone us on +46 70 3200 117.
Late Phase Solutions Europe attends ISPOR 14th Annual European Congress
October 17, 2011
November 5–8 2011, Madrid Spain
Elizabeth Hernberg-Ståhl, Senior Consultant, Late Phase Solutions Europe AB, will be one of the Course leaders for the Short Course on Patient Registries, November 5, 14.00–18.00.
If you would like to arrange a personal meeting with us during the ISPOR Congress, please contact us at info@latephasesolutions.com or phone us on +46 70 3200 117.
Late Phase Solutions Europe attends Late Phase Drug Development World 2011
October 17, 2011
December 6–8 2011, London UK
Elizabeth Hernberg-Ståhl, Senior Consultant, Late Phase Solutions Europe AB, will be one of the workshop leaders at the pre conference workshop 09.00-16.00 on December 6 "Innovative solutions to data capture".
If you would like to arrange a personal meeting with Late Phase Solutions Europe during the conference, please contact us at info@latephasesolutions.com or phone us on +46 70 3200 117
Late Phase Solutions Europe attends 2nd Annual Optimising Orphan Drug Development
October 17, 2011
January 19–20 2012, Lyon France
Elizabeth Hernberg-Ståhl, Senior Consultant, Late Phase Solutions Europe AB, will be presenting at the conference on January 20 on the topic "Challenges and Opportunities during Late Phase Drug Development of Orphan Drugs".
If you would like to arrange a personal meeting with Late Phase Solultions Europe during the conference, please contact us at info@latephasesolutions.com or phone us on +46 70 3200 117
3 day MBA in Orphan Drugs
March 29, 2011
April 18–20, 2011 London
3 day MBA in Orphan Drugs
August 22–24, 2011 Singapore
3 day MBA in Orphan Drugs
Experienced Trainer Elizabeth Hernberg-Ståhl
Elizabeth has more than thirty years experience from International Biotech and Pharmaceutical Industry, whereof the last near twenty in the Orphan Drug area.
Elizabeth joined TKT Europe 5S as one of its first employees in the year 2000, just a few month after the Orphan Drug legislation was implemented in Europe. The company launched the first orphan drug which received Orphan Drug Designation and approval in Europe under the new legislation in mid 2001.
Elizabeth was with the company for 10 years during its grew from a small European company with less than twenty employees to a global company, today under the name Shire HGT after having been acquired by Shire.
World Orphan Drugs Summit
March 29, 2011
May 31–June 1 2011, Frankfurt, Germany
Late Phase Solutions Europe AB attends World Orphan Drug Summit. If you would like to arrange a personal meeting with us during the event, please contact us at info@latephasesolutions.com or phone us on +46 70 3200 117.